The total return over the past 12 months is -8.23% vs. +16.94% for the S&P 500. So far it's up +13.38% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (8.23%) | (18.36%) | (37.50%) | (39.76%) | N/A | N/A |
| Total Return CAGR | (8.23%) | (18.36%) | (37.50%) | (39.76%) | N/A | N/A |
| Revenue CAGR | N/A | N/A | +91.55% | N/A | (20.28%) | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Cocrystal Pharma, Inc. (COCP)
| Year | Start price | End price | COCP Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $0.98 | $1.11 | +13.38% | +14.51% | (1.13%) |
| 2025 | $2.02 | $0.98 | (51.53%) | +17.72% | (69.25%) |
| 2024 | $1.72 | $2.02 | +17.44% | +24.89% | (7.45%) |
| 2023 | $1.95 | $1.72 | (11.80%) | +26.19% | (37.99%) |
| 2022 | $7.80 | $1.95 | (75.00%) | (18.17%) | (56.83%) |
| 2021 | $16.32 | $7.80 | (52.21%) | +28.74% | (80.95%) |
| 2020 | $6.00 | $16.32 | +172.00% | +18.37% | +153.63% |
| 2019 | $43.20 | $6.00 | (86.11%) | +31.22% | (117.33%) |
| 2018 | $72.00 | $43.20 | (40.00%) | (4.56%) | (35.44%) |
| 2017 | $140.40 | $72.00 | (48.72%) | +21.70% | (70.42%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
